Back

Frailty and anticoagulant prescription in older hospitalized patients with atrial fibrillation: a multi-centred observational study

1 September 2024 (18:00 - 18:40)
Organised by: Logo
Congress Presentation Part of: Cardiovascular disease in the elderly Cardiovascular Disease in the Elderly ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Doctor Tu Nguyen

The George Institute for Global Health, Sydney (Australia)

6 More presentations in this session

Presentation thumbnail
Effect of tranexamic acid in vascular surgery- a sub-study of the POISE-3 randomized clinical trial
Doctor S. Ofori (Ontario, CA)
Abstract Slides Video
Presentation thumbnail
The long-term clinical impact of high-intensity statin therapy in older patients with acute myocardial infarction
Doctor Y. Kwon (Daegu, KR)
Abstract Slides Video
Presentation thumbnail
The real-world safety of ticagrelor among older adults (above 75 years): a pharmacovigilance study from the FDA data
Doctor T. Lerman (Petah Tikva, IL)
Abstract Slides Video
Presentation thumbnail
Validation and development of a scoring system for comprehensively evaluating arterial damage in the elderly chinese
Professor Y. Zhang (Shanghai, CN)
Abstract Slides Video
Presentation thumbnail
One- and five-year mortality according to first use of ticagrelor or clopidogrel at the acute stage of myocardial infarction in elderly patients: the FAST-MI 2015 registry
Professor N. Danchin (Paris, FR)
Abstract Slides Video

Access the full session

Session thumbnail
Cardiovascular disease in the elderly

The Event

Event poster

ESC Congress 2024

1 September 2024 18:00 CET
You may be interested in
thumbnail
Congress Presentation
Risk and causes of hospital admission in patients with atrial fibrillation on treatment with oral anticoagulants
thumbnail
Congress Presentation
Impact of oral anticoagulants in frail atrial fibrillation patients: a report from an observational registry of european patients
thumbnail
Congress Presentation
Direct oral anticoagulation versus warfarin in atrial fibrillation: a nationwide cohort study of effectiveness and safety among frail patients

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources